Loading chat...

DE SB265

Bill

Status

Introduced

4/13/2022

Primary Sponsor

Spiros Mantzavinos

Click for details

Origin

Senate

151st General Assembly

AI Summary

  • Requires carriers and pharmacy benefits managers to count third-party cost-sharing assistance (payments made on behalf of patients) toward patients' deductibles and out-of-pocket limits when calculating cost-sharing obligations.

  • Limits copayment and coinsurance requirements for prescription drugs to the lesser of: the standard copayment/coinsurance, the usual and customary price, or the contract price paid to the pharmacy.

  • Applies to health benefit plans entered into, amended, extended, or renewed on or after January 1, 2024, covering both commercial insurance carriers and pharmacy benefits managers.

  • Includes exceptions for Health Savings Account-qualified High Deductible Health Plans to comply with federal tax law, allowing the requirement to apply after minimum deductibles are met, except for preventive care services.

  • Authorizes the Insurance Commissioner and State Employee Benefit Committee to promulgate rules and regulations necessary to implement and enforce the requirements.

Legislative Description

An Act To Amend Title 18 And Title 29 Of The Delaware Code To Ensure Fairness In Cost-sharing For Prescription Drugs.

Last Action

Stricken in Senate

4/14/2022

Committee Referrals

Banking, Business & Insurance4/13/2022

Full Bill Text

No bill text available